In contrast, studies on patient biopsies exhibited that RhoB expression levels are dramatically decreased in several tumor types including head and neck, lung and ovary carcinoma, when tumors become more aggressive and invasive[10, 9, 26]. The gene discussed is RHOB; the disease is ovarian carcinoma.